National Database on Primary Sclerosing Cholangitis (PSC)

In plain English

What this trial is testing

Condition(s) listed: Primary Sclerosing Cholangitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.

Who can join

• Ages 17 and older
• Any sex

Some of the main requirements, copied from the record:

• Willing and able to give informed consent prior to any study specific procedure being performed;
• Diagnosis of PSC according to the most recent published guidelines (EASL);

There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.

What's involved

• About 6000 participants are expected to take part.
• The study has 1 group.
• Start date: 2022-10-21.
• Main results expected around 2032-10-21 (estimate from the record).
• 63 study sites listed (1 marked recruiting) in Italy.

Groups in this study

• PSC population residing in Italy

Main thing being measured

• Identify and define distinct phenotypes and sub-phenotypes of PSC patients at higher risk of disease progression. (Overall duration of the study (10 years))

In the researchers’ words

Primary sclerosing cholangitis (PSC) a rare, chronic fibroinflammatory disease of the liver. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PSC patient database linked to a biological sample storage.

This summary was written automatically from the official record using fixed templates (no AI), so it only says what the record says, and may leave things out.